Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Ehlers Danlos syndrome and gastrointestinal manifestations: a 20‐year experience at Mayo Clinic
Nelson, Alfred D. , Mouchli, Mohamad, Valentin, Nelson, Deyle, David R. , Pichurin, Pavel N. , Camilleri, Michael , Acosta, Andrés

Neurogastroenterology & Motility | September 17, 2015 | Volume: 27 | Issue: 11 | Pages: 1657-1666

10.1111/nmo.12665 | PMID 26376608 Get It

Abstract Background Gastrointestinal ( GI ) manifestations are found in Ehlers Danlos syndrome ( EDS ) hypermobility subtype ( HM ). We aimed to assess associations between EDS HM and other EDS subtypes with GI manifestations. Methods We reviewed medical records of EDS patients evaluated at Mayo Clinic's Medical Genetics Clinic 1994–2013. We extracted information regarding EDS subtypes, GI manifestations, and treatments. Key Results We identified 687 patients; 378 (56%) had associated GI manifestations (female 86.8%, diagnosis mean age 29.6 years). Of the patients identified, 58.9% (43/73) had EDS classic, 57.5% (271/471) EDS HM , 47.3% (27/57) EDS vascular subtypes. In addition, 86 patients had EDS that could not be classified in any of those three subtypes. Commonest GI symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome‐like symptoms (27.5%). Many GI symptoms were commoner in EDS HM than the other subtypes together. Among 37.8% of the 378 patients who underwent esophagogastroduodenoscopy, the commonest abnormalities were gastritis, hiatal hernia and reflux esophagitis. Abnormal gastric emptying was observed in 22.3% (17/76): 11.8% delayed and 10.5% accelerated. Colonic transit was abnormal in 28.3% (13/46): 19.6% delayed and 8.7% accelerated. Rectal evacuation disorder was confirmed in 18/30 patients who underwent anorectal manometry. Angiography showed aneurysms in abdominal vessels in EDS vascular type. Proton pump inhibitors (38%) and drugs for constipation (23%) were the most commonly used medications. A minority underwent colectomy (2.9%) or small bowel surgery (4%). Conclusions & Inferences EDS HM and other subtypes should be considered in patients with chronic functional GI symptoms and abdominal vascular lesions.
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
Arai, Sally , Pidala, Joseph, Pusic, Iskra , Chai, Xiaoyu , Khera, Nandita , Palmer, Jeanne , Chen, George L. , Jagasia, Madan , Mayer, Sebastian , Wood, William A. , Hyun, Teresa S. , Inamoto, Yoshihiro , Storer, Barry E. , Shulman, Howard M., Sarantopoulos, Stefanie , Lee, Stephanie J. , Jaglowski, Samantha , Green, Michael , Miklos, David B. , Martin, Paul J. , Flowers, Mary E.D. , Chen, George , Lee, Stephanie J , Wood, William A

Clinical Cancer Research | September 16, 2015 | Volume: 22 | Issue: 2 | Pages: 319-327

10.1158/1078-0432.ccr-15-1443 | PMID 26378033 Get It

Abstract Purpose: Cutaneous sclerosis occurs in 20% of patients with chronic graft-versus-host disease (GVHD) and can compromise mobility and quality of life. Experimental design: We conducted a prospective, multicenter, randomized, two-arm phase II crossover trial of imatinib (200 mg daily) or rituximab (375 mg/m2 i.v. weekly × 4 doses, repeatable after 3 months) for treatment of cutaneous sclerosis diagnosed within 18 months (NCT01309997). The primary endpoint was significant clinical response (SCR) at 6 months, defined as quantitative improvement in skin sclerosis or joint range of motion. Treatment success was defined as SCR at 6 months without crossover, recurrent malignancy or death. Secondary endpoints included changes of B-cell profiles in blood (BAFF levels and cellular subsets), patient-reported outcomes, and histopathology between responders and nonresponders with each therapy. Results: SCR was observed in 9 of 35 [26%; 95% confidence interval (CI); 13%–43%] participants randomized to imatinib and 10 of 37 (27%; 95% CI, 14%–44%) randomized to rituximab. Six (17%; 95% CI, 7%–34%) patients in the imatinib arm and 5 (14%; 95% CI, 5%–29%) in the rituximab arm had treatment success. Higher percentages of activated B cells (CD27+) were seen at enrollment in rituximab-treated patients who had treatment success (P = 0.01), but not in imatinib-treated patients. Conclusions: These results support the need for more effective therapies for cutaneous sclerosis and suggest that activated B cells define a subgroup of patients with cutaneous sclerosis who are more likely to respond to rituximab. Clin Cancer Res; 22(2); 319–27. ©2015 AACR.
Near‐peer driven dissection selective: A primer to the medical school anatomy course
Cantwell, Sean , Bonadurer, George F., Pawlina, Wojciech, Lachman, Nirusha

Clinical Anatomy | September 16, 2015 | Volume: 28 | Issue: 8 | Pages: 985-993

10.1002/ca.22630 | PMID 26375596 Get It

In the anatomy laboratory, skill remains a critical component to unlocking the true value of learning from cadaveric dissection. However, there is little if any room for provision of instruction in proper dissection technique. We describe how near‐peer instructors designed a supplemental learning activity to enhance the dissection experience for first‐year medical students. This study aimed to evaluate the efficacy of this curriculum in improving participants' understanding of dissection technique and its impact on perceived challenges associated with the anatomy course. Curriculum was designed under faculty guidance and included didactic sessions, low‐fidelity models, dissection, student presentations, and clinical correlations. Participants' (n = 13) knowledge of basic dissection techniques and concepts were assessed before the selective, and both participants' and nonparticipants' (n = 39) knowledge was assessed at the end of week one and week seven of the anatomy course. Scores were compared using repeated measures ANOVA followed by post hoc t‐tests. Thirteen deidentified reflective essays were reviewed by four independent reviewers for themes that aligned with learning objectives. Participants in the selective course scored higher on assessment of dissection techniques and concepts one week after the selective compared to both nonparticipants and their own baseline scores before the selective. Analysis of student reflections resulted in four themes: confidence with dissection skill, sharing resources and transfer of knowledge, learning environment, and psychological impact of perceived challenges of the anatomy course. Near‐peer driven supplemental exercises are effective in facilitating dissection skills. This dissection primer increases student confidence and alleviates apprehension associated with anatomy courses. Clin. Anat. 28:985–993, 2015. © 2015 Wiley Periodicals, Inc.
Interictal photosensitivity associates with altered brain structure in patients with episodic migraine
Chong, Catherine D. , Starling, Amaal J. , Schwedt, Todd J. , Chong, Catherine D

Cephalalgia | September 16, 2015 | Volume: 36 | Issue: 6 | Pages: 526-533

10.1177/0333102415606080 | PMID 26378082 Get It

Background Migraine attacks manifest with hypersensitivities to light, sound, touch and odor. Some people with migraine have photosensitivity between migraine attacks, suggesting persistent alterations in the integrity of brain regions that process light. Although functional neuroimaging studies have shown visual stimulus induced “hyperactivation” of visual cortex regions in migraineurs between attacks, whether photosensitivity is associated with alterations in brain structure is unknown. Methods Levels of photosensitivity were evaluated using the Photosensitivity Assessment Questionnaire in 48 interictal migraineurs and 48 healthy controls. Vertex-by-vertex measurements of cortical thickness were assessed in 28 people with episodic migraine who had interictal photosensitivity (mean age = 35.0 years, SD = 12.1) and 20 episodic migraine patients without symptoms of interictal photosensitivity (mean age = 36.0 years, SD = 11.4) using a general linear model design. Results Migraineurs have greater levels of interictal photosensitivity relative to healthy controls. Relative to migraineurs without interictal photosensitivity, migraineurs with interictal photosensitivity have thicker cortex in several brain areas including the right lingual, isthmus cingulate and pericalcarine regions, and the left precentral, postcentral and supramarginal regions. Conclusion Episodic migraineurs with interictal photosensitivity have greater cortical thickness in the right parietal-occipital and left fronto-parietal regions, suggesting that persistent light sensitivity is associated with underlying structural alterations.
Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing
Tschumper, Renee C. , Asmann, Yan W. , Hossain, Asif, Huddleston, P.M. , Wu, Xiaosheng , Eckloff, Bruce W., Jelinek, Diane F., Dispenzieri, Angela , Huddleston, Paul M

Oncotarget | September 16, 2015 | Volume: 3 | Issue: 4 | Pages: 502-513

10.18632/oncotarget.469 | PMID 22522905 Get It

The Hitchhiker's Guide to Virotherapy
Vile, Richard G. , Pandha, Hardev , Harrington, Kevin J. , Melcher, Alan , Donnelly, Oliver , Melcher, Alan A , Harrington, Kevin

Oncotarget | September 16, 2015 | Volume: 3 | Issue: 8 | Pages: 735-736

10.18632/oncotarget.627 | PMID 22964541 Get It

Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts
Higgins, Dominique , Wang, Ruisi, Milligan, Brian D., Carlson, Brett L. , Pokorny, Jenny L. , Cheshier, Samuel , Meyer, Fredric B. , Henley, John R. , Higgins, Dominique M, Schroeder, Mark A. , Weissman, Irving L. , Sarkaria, Jann N.

Oncotarget | September 16, 2015 | Volume: 4 | Issue: 5 | Pages: 792-801

10.18632/oncotarget.1059 | PMID 23801022 Get It

A Hidden Role of the Inactivated FANCD2: Upregulating ΔNp63
Panneerselvam, Jayabal, Pickering, Anna, Tian, Hui , Zheng, Junnian , Fei, Peiwen, Zhang, Jun , Wang, Hong

Oncotarget | September 16, 2015 | Volume: 4 | Issue: 9 | Pages: 1416-1426

10.18632/oncotarget.1217 | PMID 23965832 Get It

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients
Preus, Leah, Yan, Li , Long, Mark D. , Morrison, Carl D., Nesline, Mary , Johnson, Candace S. , Liu, Song , Trump, Donald L. , Sucheston‐Campbell, Lara E. , Campbell, Moray J. , Singh, Prashant Kumar , Hu, Qiang , Morrison, Carl D., Koochekpour, Shahriar , Kohli, Manish , Campbell, Moray J

Oncotarget | September 16, 2015 | Volume: 5 | Issue: 3 | Pages: 824-840

10.18632/oncotarget.1776 | PMID 24583788 Get It